Pharmacodynamic aspects of drug administration. Tolerance development

Advanced Drug Delivery Reviews

Volumn 33, Issue 3, 1998, Pages 235-240

  Paalzow, Lennart K ^a   Själander Brynne, Lena ^a  

^a Department of Pharmacy   (Sweden)

Author keywords

l dopa; Pharmacodynamic models; Pharmacodynamic tolerance; Pharmacokinetics; Propranolol; Rebound effects; Tolerance

Indexed keywords

DISEASES; DRUG INFUSION; PHARMACOKINETICS;

LEVODOPA; PROPANOLOL;

CONTROLLED DRUG DELIVERY;

CARBIDOPA; DUODOPA; LEVODOPA; PROPRANOLOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TOLERANCE; FEMALE; HUMAN; HYPERTENSION; INTRADUODENAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PARKINSON DISEASE; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; SHORT SURVEY; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0345055782     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00031-3     Document Type: Review

References (20)

1. A.S. Nies, S.P. Spielberg, Principles of therapeutics, in: J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A. Goodman Gilman (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, 1996, pp. 43-62.
2. Houston M.C., Hodge R. Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases. Am. Heart J. 116:1988;515-523.
3. Shoulson I., Glaubiger G.A., Chase T.N. On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology. 25:1975;1144-1148.
4. Quinn N., Parkes J.D., Marsden C.D. Control on/off phenomenon by continuous intravenous levodopa. Neurology. 34:1984;1131-1136.
5. Hardie R.J., Lees A.J., Stern G.M. On-off fluctuations in Parkinson's disease: a clinical and neuropharmacological study. Brain. 107:1984;487-506.
6. J.G. Nutt, W.R. Woodward, J.P. Hammerstad, Pharmacokinetics of intravenous levodopa: implications for mechanisms of therapeutic actions of levodopa and carbidopa, in: S. Fahn, C.D. Marsden, P. Jenner, P. Teychenne (Eds.), Recent Developments in Parkinson's Disease, Raven Press, New York, 1986, pp. 239-245.
7. Cedarbaum J.M., Kutt H., McDowell F.H. A pharmacokinetic and pharmacodynamic comparison of Sinemet CR (50/200) and standard Sinemet (25/100). Neurology. 39:1989;38-44.
8. Bredberg E., Nilsson D., Johansson K., Aquilonious S.-M., Johnels B., Nyström C., Paalzow L. Intraduodenal infusion of a water-based levodopa dispersion for optimisation of the therapeutic effect in severe Parkinson's disease. Eur. J. Clin. Pharmacol. 45:1993;117-122.
9. D. Nilsson, S.-M. Aquilonius, T. Lundqvist, C. Nyström, L. Paalzow, Long term pharmacokinetic and pharmacodynamic studies of intraduodenal levodopa infusion in severe Parkinson's disease. Eur. J. Clin. Pharmacol. 1997, in press.
10. Johnels B., Ingvarsson P.E., Thorselius M., Valls M., Steg G. Disability profiles and objective quantitative assessment in Parkinson's disease. Acta Neurol. Scand. 79:1989;227-238.
11. Grandas F., Obeso J.A. Motor response following repeated apomorphine administration is reduced in Parkinson's disease. Clin. Neurol. 12:1989;14-22.
12. Nutt J.G., Carter J.H., Woodward W.R. Effect of brief levodopa holidays on the short-duration response to levodopa. Evidence for tolerance to the antiparkinsonian effects. Neurology. 44:1994;1617-1622.
13. Weiner W.J., Koller W.C., Perlik S., Nausieda P.A., Klawans H.L. Drug holiday and management of Parkinson disease. Neurology. 30:1980;1257-1261.
14. Kaye J.A., Feldman R.G. The role of L-Dopa holiday in the long-term management of Parkinson's disease. Clin. Neuropharmacol. 9:1986;1-13.
15. Hager W.D., Pieniaszek H.J., Perrier D., Mayersohn M., Goldberger V. Assessment of beta blockade with propranolol. Clin. Pharmacol. Ther. 30:1981;282-290.
16. Sheiner L.B., Stanski D.R., Vozeh S., Miller R.D., Ham J. Simultaneous modelling of pharmacokinetics and pharmacodynamics: application to D-tubocurarine. Clin. Pharmacol. Ther. 244:1979;358-371.
17. Ekblom M., Hammarlund-Udenaes M., Paalzow L. Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats. J. Pharmacol. Exp. Ther. 266:1993;244-252.
18. Mandema J.W., Wada D.R. Pharmacodynamic model for acute tolerance development to electroencephalographic effects of alfentanilin in the rat. J. Pharmacol. Exp. Ther. 275:1995;1185-1194.
19. Dayneka N.L., Garg V., Jusko W.J. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 21:1993;457-478.
20. J. Gabrielsson, D. Weiner, Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, Swedish Pharmaceutical Press, Stockholm, 1994, pp. 631-636.